Skip to main content

Matrix Metalloproteinase-14 Expression and Its Prognostic Value in Cervical Carcinoma

Abstract

The objective of the study was to evaluate the expression of matrix metalloproteinase-14 (MMP-14) in cervical carcinoma and correlate its expression with clinicopathological parameters, recurrence, and survival of the patients. The expressions of MMP-14 in normal cervical mucosa and cervical carcinoma tissue were detected with immunohistochemistry. Survival analysis by the Kaplan–Meier method was performed to assess prognostic significance. The positive expression rate of MMP-14 in cervical carcinoma tissue was 81.6 %(111/136), and there was significant difference on their positive expression rates between in cervical carcinoma tissue and in normal cervical mucosa(22.4 %)(13/58)(P < 0.05);The positive expression rates of MMP-14 in patients with poor histologic differentiation, lymph node metastasis, and recurrence group were heightened. Using Kaplan–Meier analysis, a comparison of survival curves of low versus high expressions of MMP-14 revealed a highly significant difference in human cervical carcinoma tissue (P < 0.05), which suggests that overexpression of MMP-14 is associated with a worse prognosis. The MMP-14 which promotes angiogenes is associated with lymph node metastasis, vascular invasion, and poor prognosis of cervical carcinoma. The current study shows that MMP-14 may be an independent prognostic factor for cervical carcinoma patients.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

  1. Devy, L., Huang, L., Naa, L., Yanamandra, N., Pieters, H., et al. (2009). Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis. Cancer Research, 69, 1517–1526.

    PubMed  Article  CAS  Google Scholar 

  2. Kim, G. E., Kim, J. H., Lee, K. H., Choi, Y. D., Lee, J. S., et al. (2012). Stromal matrix metalloproteinase-14 expression correlates with the grade and biological behavior of mammary phyllodes tumors. Applied Immunohistochemistry & Molecular Morphology, 20, 298–303.

    Article  CAS  Google Scholar 

  3. Zhang, H., Qi, M., Li, S., Qi, T., Mei, H., et al. (2012). microRNA-9 targets matrix metalloproteinase 14 to inhibit invasion, metastasis, and angiogenesis of neuroblastoma cells. Molecular Cancer Therapeutics, 11, 1454–1466.

    PubMed  Article  Google Scholar 

  4. Watanabe, H. (2010). Extracellular matrix–regulation of cancer invasion and metastasis. Gan To Kagaku Ryoho, 37, 2058–2061.

    PubMed  CAS  Google Scholar 

  5. Tee, Y. T., Han, C. P., Ko, J. L., Chen, G. D., Yang, S. F., et al. (2007). Evaluation of matrix metalloproteinase 2 expression in cervical carcinogenesis using tissue array and integrated optical density for immunoreactivity. Reproductive Sciences, 14, 719–726.

    PubMed  Article  CAS  Google Scholar 

  6. Zarrabi, K., Dufour, A., Li, J., Kuscu, C., Pulkoski-Gross, A., et al. (2011). Inhibition of matrix metalloproteinase 14 (MMP-14) -mediated cancer cell migration. Journal of Biological Chemistry, 286, 33167–33177.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  7. Chen, T. Y., Li, Y. C., Liu, Y. F., Tsai, C. M., Hsieh, Y. H., et al. (2011). Role of MMP14 gene polymorphisms in susceptibility and pathological development to hepatocellular carcinoma. Annals of Surgical Oncology, 18, 2348–2356.

    PubMed  Article  Google Scholar 

  8. Dong, Q., Yu, D., Yang, C. M., Jiang, B., & Zhang, H. (2010). Expression of the reversion-inducing cysteine-rich protein with Kazal motifs and matrix metalloproteinase-14 in neuroblastoma and the role in tumour metastasis. International Journal of Experimental Pathology, 91, 368–373.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  9. Laudański, P., Swiatecka, J., Kozłowski, L., Leśniewska, M., Wojtukiewicz, M., et al. (2010). Increased serum level of membrane type 1-matrix metalloproteinase (MT1-MMP/MMP-14) in patients with breast cancer. Folia Histochemica et Cytobiologica, 48, 101–103.

    PubMed  Google Scholar 

  10. Littlepage, L. E., Sternlicht, M. D., Rougier, N., Phillips, J., Gallo, E., et al. (2010). Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression. Cancer Research, 70, 2224–2234.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  11. Fidler, I. J. (2000). Angiogenesis and cancer metastasis. Cancer Journal, 2, S134–S141.

    Google Scholar 

  12. Cork, S. M., Kaur, B., Devi, N. S., Cooper, L., Saltz, J., et al. (2012). A proprotein convertase/MMP-14 proteolytic cascade releases a novel 40 kDa vasculostatin from tumor suppressor BAI1. Oncogene, 31(50), 5144–5152.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  13. Aplin, A. C., Zhu, W. H., Fogel, E., & Nicosia, R. F. (2009). Vascular regression and survival are differentially regulated by MT1-MMP and TIMPs in the aortic ring model of angiogenesis. American Journal of Physiology. Cell Physiology, 297, C471–C480.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  14. Devy, L., Huang, L., Naa, L., Yanamandra, N., Pieters, H., et al. (2009). Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis. Cancer Research, 69, 1517–1526.

    PubMed  Article  CAS  Google Scholar 

  15. Roebuck, M. M., Helliwell, T. R., Chaudhry, I. H., Kalogrianitis, S., Carter, S., et al. (2005). Matrix metalloproteinase expression is related to angiogenesis and histologic grade in spindle cell soft tissue neoplasms of the extremities. American Journal of Clinical Pathology, 123, 405–414.

    PubMed  Article  Google Scholar 

  16. Ricke, W. A., Smith, G. W., Reynolds, L. P., Redmer, D. A., & Smith, M. F. (2002). Matrix metalloproteinase (2, 9, and 14) expression, localization, and activity in ovine corpora lutea throughout the estrous cycle. Biology of Reproduction, 66, 1083–1094.

    PubMed  Article  CAS  Google Scholar 

  17. Niewiarowska, J., Brézillon, S., Sacewicz-Hofman, I., Bednarek, R., Maquart, F. X., et al. (2011). Lumican inhibits angiogenesis by interfering with α2β1 receptor activity and downregulating MMP-14 expression. Thrombosis Research, 128, 452–457.

    PubMed  Article  CAS  Google Scholar 

  18. Heikkilä, P., Teronen, O., Hirn, M. Y., Sorsa, T., Tervahartiala, T., et al. (2003). Inhibition of matrix metalloproteinase-14 in osteosarcoma cells by clodronate. Journal of Surgical Research, 111, 45–52.

    PubMed  Article  Google Scholar 

  19. Naglich, J. G., Jure-Kunkel, M., Gupta, E., Fargnoli, J., Henderson, A. J., et al. (2001). Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291. Cancer Research, 61, 8480–8485.

    PubMed  CAS  Google Scholar 

  20. Zhai, Y., Hotary, K. B., Nan, B., Bosch, F. X., Muñoz, N., et al. (2005). Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion. Cancer Research, 65, 6543–6550.

    PubMed  Article  CAS  Google Scholar 

  21. Shields, M. A., Dangi-Garimella, S., Redig, A. J., & Munshi, H. G. (2012). Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression. Biochemical Journal, 441, 541–552.

    PubMed  Article  CAS  Google Scholar 

  22. Poincloux, R., Lizárraga, F., & Chavrier, P. (2009). Matrix invasion by tumour cells: A focus on MT1-MMP trafficking to invadopodia. Journal of Cell Science, 122, 3015–3024.

    PubMed  Article  CAS  Google Scholar 

  23. Wolf, K., Wu, Y. I., Liu, Y., Geiger, J., Tam, E., et al. (2007). Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nature Cell Biology, 9, 893–904.

    PubMed  Article  CAS  Google Scholar 

  24. von Lampe, B., Barthel, B., Coupland, S. E., Riecken, E. O., & Rosewicz, S. (2000). Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut, 47, 63–73.

    Article  Google Scholar 

  25. Kim, J. H., Kim, T. H., Jang, J. W., Jang, Y. J., Lee, K. H., et al. (2001). Analysis of matrix metalloproteinase mRNAs expressed in hepatocellular carcinoma cell lines. Molecules and Cells, 12, 32–40.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors are very grateful to Zhigao Xu (M.D., Department of Pathology, Zhongnan Hospital of Wuhan University) for his excellent technical support.

Conflict of interest

The authors declare no conflicts of interest.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Fenglian Pan.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wang, H., Zhang, X., Huang, L. et al. Matrix Metalloproteinase-14 Expression and Its Prognostic Value in Cervical Carcinoma. Cell Biochem Biophys 70, 729–734 (2014). https://doi.org/10.1007/s12013-014-9974-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-014-9974-8

Keywords

  • Cervical carcinoma
  • MMP-14
  • Prognosis
  • Survival